HL7 Terminology (THO)
5.4.0 - Publication International flag

This page is part of the HL7 Terminology (v5.4.0: Release) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ValueSet: PHVS_ManufacturersOfVaccinesMVX_CDC_NIP

Official URL: http://terminology.hl7.org/ValueSet/v2-0227 Version: 4.0.0
Active as of 2023-06-12 Responsible: Health Level Seven International Computable Name: PHVSManufacturersOfVaccinesMVXCDCNIP
Other Identifiers: id: Uniform Resource Identifier (URI)#urn:oid:2.16.840.1.114222.4.11.826

Copyright/Legal: This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license

Value Set of codes that specify the organization that manufactures a vaccine. The values are maintained by the US Centers of Disease Control. Note that the source of truth for these code values are maintained by the CDC, and the code system may be accessed via https://phinvads.cdc.gov/vads/ViewCodeSystem.action?id=2.16.840.1.113883.12.227

References

This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)

Logical Definition (CLD)

 

Expansion

This value set contains 82 concepts

Expansion based on:

  • codesystem http://hl7.org/fhir/sid/mvx version 20201030
  • system http://hl7.org/fhir/sid/mvx version 20201030
CodeSystemDisplay
  ABhttp://hl7.org/fhir/sid/mvxAbbott Laboratories
  ACAhttp://hl7.org/fhir/sid/mvxAcambis, Inc
  ADhttp://hl7.org/fhir/sid/mvxAdams Laboratories, Inc.
  ALPhttp://hl7.org/fhir/sid/mvxAlpha Therapeutic Corporation
  ARhttp://hl7.org/fhir/sid/mvxArmour
  AVBhttp://hl7.org/fhir/sid/mvxAventis Behring L.L.C.
  AVIhttp://hl7.org/fhir/sid/mvxAviron
  BAhttp://hl7.org/fhir/sid/mvxBaxter Healthcare Corporation-inactive
  BAHhttp://hl7.org/fhir/sid/mvxBaxter Healthcare Corporation
  BAYhttp://hl7.org/fhir/sid/mvxBayer Corporation
  BPhttp://hl7.org/fhir/sid/mvxBerna Products
  BPChttp://hl7.org/fhir/sid/mvxBerna Products Corporation
  BTPhttp://hl7.org/fhir/sid/mvxBiotest Pharmaceuticals Corporation
  MIPhttp://hl7.org/fhir/sid/mvxEmergent BioSolutions
  CSLhttp://hl7.org/fhir/sid/mvxbioCSL
  CNJhttp://hl7.org/fhir/sid/mvxCangene Corporation
  CMPhttp://hl7.org/fhir/sid/mvxCelltech Medeva Pharmaceuticals
  CENhttp://hl7.org/fhir/sid/mvxCenteon L.L.C.
  CHIhttp://hl7.org/fhir/sid/mvxChiron Corporation
  CONhttp://hl7.org/fhir/sid/mvxConnaught
  DVChttp://hl7.org/fhir/sid/mvxDynPort Vaccine Company, LLC
  EVNhttp://hl7.org/fhir/sid/mvxEvans Medical Limited
  GEOhttp://hl7.org/fhir/sid/mvxGeoVax Labs, Inc.
  SKBhttp://hl7.org/fhir/sid/mvxGlaxoSmithKline
  GREhttp://hl7.org/fhir/sid/mvxGreer Laboratories, Inc.
  IAGhttp://hl7.org/fhir/sid/mvxImmuno International AG
  IUShttp://hl7.org/fhir/sid/mvxImmuno-U.S., Inc.
  INThttp://hl7.org/fhir/sid/mvxIntercell Biomedical
  KGChttp://hl7.org/fhir/sid/mvxKorea Green Cross Corporation
  LEDhttp://hl7.org/fhir/sid/mvxLederle
  MBLhttp://hl7.org/fhir/sid/mvxMassachusetts Biologic Laboratories
  MAhttp://hl7.org/fhir/sid/mvxMassachusetts Public Health Biologic Laboratories
  MEDhttp://hl7.org/fhir/sid/mvxMedImmune, Inc. (AstraZeneca)
  MSDhttp://hl7.org/fhir/sid/mvxMerck and Co., Inc.
  IMhttp://hl7.org/fhir/sid/mvxMerieux
  MILhttp://hl7.org/fhir/sid/mvxMiles
  NABhttp://hl7.org/fhir/sid/mvxNABI
  NYBhttp://hl7.org/fhir/sid/mvxNew York Blood Center
  NAVhttp://hl7.org/fhir/sid/mvxNorth American Vaccine, Inc.
  NOVhttp://hl7.org/fhir/sid/mvxNovartis Pharmaceutical Corporation
  NVXhttp://hl7.org/fhir/sid/mvxNovavax, Inc.
  OTChttp://hl7.org/fhir/sid/mvxOrganon Teknika Corporation
  ORThttp://hl7.org/fhir/sid/mvxOrtho-clinical Diagnostics
  PDhttp://hl7.org/fhir/sid/mvxParkedale Pharmaceuticals
  PWJhttp://hl7.org/fhir/sid/mvxPowderJect Pharmaceuticals
  PRXhttp://hl7.org/fhir/sid/mvxPraxis Biologics
  JPNhttp://hl7.org/fhir/sid/mvxThe Research Foundation for Microbial Diseases of Osaka University (BIKEN)
  PMChttp://hl7.org/fhir/sid/mvxSanofi Pasteur
  SCLhttp://hl7.org/fhir/sid/mvxSclavo, Inc.
  SOLhttp://hl7.org/fhir/sid/mvxSolvay Pharmaceuticals
  SIhttp://hl7.org/fhir/sid/mvxSwiss Serum and Vaccine Inst.
  TALhttp://hl7.org/fhir/sid/mvxTalecris Biotherapeutics
  USAhttp://hl7.org/fhir/sid/mvxUnited States Army Medical Research and Material Command
  VXGhttp://hl7.org/fhir/sid/mvxVaxGen
  WAhttp://hl7.org/fhir/sid/mvxWyeth-Ayerst
  WALhttp://hl7.org/fhir/sid/mvxWyeth
  ZLBhttp://hl7.org/fhir/sid/mvxZLB Behring
  OTHhttp://hl7.org/fhir/sid/mvxOther manufacturer
  UNKhttp://hl7.org/fhir/sid/mvxUnknown manufacturer
  AKRhttp://hl7.org/fhir/sid/mvxAkorn, Inc
  PFRhttp://hl7.org/fhir/sid/mvxPfizer, Inc
  BRRhttp://hl7.org/fhir/sid/mvxBarr Laboratories
  JNJhttp://hl7.org/fhir/sid/mvxJohnson and Johnson
  PSChttp://hl7.org/fhir/sid/mvxProtein Sciences
  IDBhttp://hl7.org/fhir/sid/mvxID Biomedical
  GRFhttp://hl7.org/fhir/sid/mvxGrifols
  CRUhttp://hl7.org/fhir/sid/mvxCrucell
  KEDhttp://hl7.org/fhir/sid/mvxKedrion Biopharma
  PAXhttp://hl7.org/fhir/sid/mvxPaxVax
  MCMhttp://hl7.org/fhir/sid/mvxMCM Vaccine Company
  SEQhttp://hl7.org/fhir/sid/mvxSeqirus
  VALhttp://hl7.org/fhir/sid/mvxValneva
  DYNhttp://hl7.org/fhir/sid/mvxDynaport
  DVXhttp://hl7.org/fhir/sid/mvxDynavax, Inc.
  DSIhttp://hl7.org/fhir/sid/mvxDispensing Solutions
  REBhttp://hl7.org/fhir/sid/mvxRebel Distributors
  VEThttp://hl7.org/fhir/sid/mvxVetter Pharma Fertigung GmbH & Co. KG
  TVAhttp://hl7.org/fhir/sid/mvxTEVA Pharmaceuticals USA
  BNhttp://hl7.org/fhir/sid/mvxBavarian Nordic A/S
  MODhttp://hl7.org/fhir/sid/mvxModerna US, Inc.
  ASZhttp://hl7.org/fhir/sid/mvxAstraZeneca
  JSNhttp://hl7.org/fhir/sid/mvxJanssen

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionAuthorCustodianComment
2023-11-14reviseMarc DuteauTSMGAdd standard copyright and contact to internal content; up-476
2020-05-06reviseTed KleinVocabulary WGMigrated to the UTG maintenance environment and publishing tooling.